Amesite is an early-stage AI software company focused on the post-acute healthcare market. Its core product, NurseMagic, is an AI-powered app for nurses and caregivers that helps reduce documentation time, simplify patient communication, and support daily workflow tasks like nursing notes and medication guidance. NurseMagic targets post-acute care organizations — home health agencies, skilled nursing facilities, hospice providers, and assisted living centers. Amesite sells NurseMagic through two channels: a B2C free app (with paid premium tiers) aimed at individual nurses, and a B2B enterprise subscription platform sold directly to care organizations. The B2C app serves a dual purpose — building a user base among frontline practitioners while reducing friction in enterprise sales, since decision-makers whose staff already use the free app are easier to convert into paying enterprise customers. Enterprise subscriptions scale with organization size and require no integration with existing systems, which Amesite argues accelerates deployment and lowers adoption barriers. The company also operates a legacy corporate and higher-education learning platform, Amesite Engage, but has deprioritized it to focus entirely on NurseMagic. Amesite is a very small business with just 6 full-time employees and 2 consultants as of mid-2025.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →